Caught Between Efficacy and Risk: The Difficult Calculus of Prescribing Cipro Against Drug-Resistant Infections
When multidrug-resistant bacteria leave physicians with few treatment options, ciprofloxacin often remains on the table—but not without serious caveats. This article examines how clinicians navigate the tension between Cipro's proven power against resistant pathogens and its well-documented capacity for lasting harm. Understanding this balancing act is essential for any patient facing a serious or complicated infection.